<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01677221</url>
  </required_header>
  <id_info>
    <org_study_id>Acleara-01</org_study_id>
    <nct_id>NCT01677221</nct_id>
  </id_info>
  <brief_title>Effects of Acleara Needle Insert on Acne</brief_title>
  <official_title>A Clinical Trial Investigating the Effects of Acleara Needle Insert on Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theravant Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theravant Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, open-label study will be conducted in 15 healthy subjects per clinical site
      ages 14 or older who meet the inclusion/exclusion criteria. Each subject may have up to 5
      lesions treated on the face, chest or back with the Acleara insert. Subjects will receive up
      to 3 follow up visits and evaluated for improvement in acne lesions and monitored for any
      adverse events.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subject assessment of reduction in acne lesion size</measure>
    <time_frame>24-72 hours, 1-2 weeks, 1 month</time_frame>
    <description>Percentage range of lesion reduction</description>
  </primary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Acne Vulgaris</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acleara Acne Treatment System</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects &gt;14 years of age

          -  Subject has mild to moderate acne vulgaris on the face, chest or back.

          -  Subject has one or more inflammatory acne lesions on face, chest or back.

          -  Willingness to participate in the study

          -  Informed consent agreement signed by the subject

          -  Willingness to follow the treatment schedule and post treatment care requirements

          -  Willingness to remain on current acne therapy as directed by the Investigator.

        Exclusion Criteria:

          -  Subject has an infection or other dermatologic condition (aside from acne) in the area
             to be treated

          -  Subject is immunosuppressed

          -  Subject is unable to comply with treatment or follow-up visits

          -  Any other condition or laboratory value that would, in the professional opinion of the
             investigator, potentially affect the subject's response or the integrity of the data
             or would pose an unacceptable risk to the subject.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Charles County Dermatology Associates</name>
      <address>
        <city>White Plains</city>
        <state>Maryland</state>
        <zip>20695-3064</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bellaire Dermatology Associates</name>
      <address>
        <city>Bellaire</city>
        <state>Texas</state>
        <zip>77401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2012</study_first_submitted>
  <study_first_submitted_qc>August 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2012</study_first_posted>
  <last_update_submitted>January 9, 2013</last_update_submitted>
  <last_update_submitted_qc>January 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acne</keyword>
  <keyword>inflammatory acne</keyword>
  <keyword>intense pulsed light</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Benzoyl Peroxide</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 12, 2015</submitted>
    <returned>May 29, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

